Physiological Effect: Vasodilation
✉ Email this page to a colleague
Drugs with Physiological Effect: Vasodilation
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan | EPOPROSTENOL SODIUM | epoprostenol sodium | INJECTABLE;INJECTION | 213913-002 | Jun 12, 2024 | AP2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm | EPOPROSTENOL SODIUM | epoprostenol sodium | INJECTABLE;INJECTION | 210473-001 | Jan 15, 2021 | AP2 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm | EPOPROSTENOL SODIUM | epoprostenol sodium | INJECTABLE;INJECTION | 210473-002 | Jan 15, 2021 | AP2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |